Summary
Chronic infection with the Hepatitis C virus results in slowly progressive liver injury characterized by hepatic necroinflammation, progressive fibrosis, and hepatocellular carcinoma. Liver injury results from a combination of immunemediated and direct viral effects. The HCV core protein has been shown to produce oxidative stress when overexpressed in multiple different cell lines as well as in the livers of transgenic mice. The mechanisms of core-induced oxidative stress are not certain, but core protein partially localizes in mitochondria and thus may alter mitochondrial respiration resulting in an increased production of reactive oxygen species. Core-induced oxidative stress produces different consequences in different cell types. In Huh-7 human hepatoma cells, it results in increased lipid peroxidation and induction of antioxidant gene expression. Potential pathological consequences of core-induced oxidative stress include DNA damage, lipid peroxidation, cell cycle dysregulation, and stellate cell activation. These in turn contribute to cell death, fibrogenesis, and carcinogenesis, as seen in patients with chronic hepatitis C. Modulation of oxidative stress may therefore have the potential to modify the clinical course of hepatitis C.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Alter MJ (1997) Epidemiology of hepatitis C. Hepatology 26: 62S - 65S
Hoofnagle JH (1997) Hepatitis C: the clinical spectrum of disease. Hepatology 26: 15S - 20S
Ostapowicz G, Watson KJ, Locarnini SA, Desmond PV (1998) Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology 27: 1730–1735
Jacobson Brown PM, Neuman MG (2001) Immunopathogenesis of hepatitis C viral infection: Thl/Th2 responses and the role of cytokines. Clin Biochem 34: 167–171
Kato N (2001) Molecular virology of hepatitis C virus. Acta Med Okayama 55: 133159
Collier J, Heathcote J (1998) Hepatitis C viral infection in the immunosuppressed patient. Hepatology 27: 2–6
Fujie H, Yotsuyanagi H, Moriya K, Shintani Y, Tsutsumi T, Takayama T, Makuuchi M, Matsuura Y, Miyamura T, Kimura S, Koike K (1999) Steatosis and intrahepatic hepatitis C virus in chronic hepatitis. J Med Virol 59: 141–145
Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G (2001) Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33: 1358–1364
Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, Matsuura Y, Miyamura T, Koike K (1997) Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 78: 1527–1531
Lerat H, Honda M, Beard MR, Loesch K, Sun J, Yang Y, Okuda M, Gosert R, Xiao SY, Weinman SA, Lemon SM (2002) Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 122: 352–365
Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM (1997) Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 94: 2557–2562
Shimotohno K (2000) Hepatitis C virus and its pathogenesis. Semin Cancer Biol 10: 233–240
Reed KE, Rice CM (2000) Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 242: 55–84
Thannickal VJ, Fanburg BL (2000) Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279: L1005 - L1028
Barbaro G, Di Lorenzo G, Asti A, Ribersani M, Belloni G, Grisorio B, Filice G, Barbarini G (1999) Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings. Am J Gastroenterol 94: 2198–2205
Kageyama F, Kobayashi Y, Kawasaki T, Toyokuni S, Uchida K, Nakamura H (2000) Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid per-oxidation in chronic hepatitis C. Am J Gastroenterol 95: 1041–1050
Paradis V, Mathurin P, Kollinger M, Imbert-Bismut F, Charlotte F, Piton A, Opolon P, Holstege A, Poynard T, Bedossa P (1997) In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J Clin Pathol 50: 401–406
Larrea E, Beloqui O, Munoz-Navas MA, Civeira MP, Prieto J (1998) Superoxide dismutase in patients with chronic hepatitis C virus infection. Free Radic Biol Med 24: 1235–1241
Houglum K, Venkataramani A, Lyche K, Chojkier M (1997) A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C. Gastroenterology 113: 1069–1073
Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, Weinman SA (2002) Mitochondrial injury, oxidative stress and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122: 352–365
Lai MM, Ware CF (2000) Hepatitis C virus core protein: possible roles in viral pathogenesis. Curr Top Microbiol Immunol 242: 117–134
Susin SA, Larochette N, Geuskens M, Kroemer G (2000) Purification of mitochondria for apoptosis assays. Methods Enzymol 322: 205–208
Fernandez-Checa JC, Garcia-Ruiz C, Colell A, Morales A, Mari M, Miranda M, Ardite E (1998) Oxidative stress: role of mitochondria and protection by glutathione. Biofactors 8: 7–11
Doussiere J, Gaillard J, Vignais PV (1999) The heme component of the neutrophil NADPH oxidase complex is a target for aryliodonium compounds. Biochemistry 38: 3694–3703
Li Y, Trush MA (1998) Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem Biophys Res Commun 253: 295–299
Palmiter RD (1998) The elusive function of metallothioneins. Proc Natl Acad Sci USA 95: 8428–8430
Moriya K, Nakagawa K, Santa T, Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Miyazawa T, Ishibashi K, Horie T, Imai K, Todoroki T, Kimura S, Koike K (2001) Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 61: 4365–4370
Cai J, Jones DP (1999) Mitochondrial redox signaling during apoptosis. J Bioenerg Biomembr 31: 327–334
Poli G (2000) Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 21: 49–98
Kato N, Yoshida H, Kioko O, Kato J, Goto T, Otsuka M, Lan K, Matsushima K, Shiratori Y, Ornata M (2000) Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer. Hepatology 32: 405–412
Factor VM, Laskowska D, Jensen MR, Woitach JT, Popescu NC, Thorgeirsson SS (2000) Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model. Proc Natl Acad Sci USA 97: 2196–2201
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Japan
About this paper
Cite this paper
Weinman, S.A. et al. (2003). Role of Core Protein-Induced Oxidative Stress in the Pathogenesis of Hepatitis C. In: Okita, K. (eds) HCV/Oxidative Stress and Liver Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-67005-6_2
Download citation
DOI: https://doi.org/10.1007/978-4-431-67005-6_2
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-67007-0
Online ISBN: 978-4-431-67005-6
eBook Packages: Springer Book Archive